If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Director/PDMR Shareholding

7 Apr 2025 10:21

RNS Number : 9177D
Argentex Group PLC
07 April 2025
 

7 April 2025

 

 

Argentex Group PLC

("Argentex" or the "Group")

 

Director / PDMR Dealing

 

Argentex Group PLC (AIM: AGFX), the global specialist in currency risk management and alternative banking announces that Tim Haldenby, independent non-executive director, on 4 April 2025 purchased 32,494 ordinary shares of £0.0001 each ("Ordinary Shares") in the Company at a price of 46.12 pence per Ordinary Share.

 

Following this transaction, Tim Haldenby's total beneficial interest in the Company is 54,716 Ordinary Shares representing approximately 0.05% of the Company's issued share capital.

 

For further information, please contact:

 

Argentex Group PLC

Jim Ormonde - Chief Executive Officer

Guy Rudolph - Chief Financial Officer

investorrelations@argentex.com

 

Teneo (Financial PR)

James Macey-White/Victoria Boxall/ Riann Cato

argentex@teneo.com, 020 7260 2700

 

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / James Todd

020 7496 3000

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Tim Haldenby

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Independent non-executive director

b)

 

Initial notification /Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Argentex Group plc

b)

 

LEI

 

 2549007V7B928Q178194

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.0001 each

Identification code

GB00BJLPH056 (Ordinary Shares) 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

46.12p

32,494

d)

 

Aggregated information

- Aggregated volume

n/a

- Price

e)

 

Date of the transaction

 

 

 4 April 2025

f)

 

Place of the transaction

 

 

London Stock Exchange, AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFFASIIDIIE
Date   Source Headline
11th Jun 20253:35 pmRNSResult of AGM
11th Jun 20251:37 pmRNSReplacement: Result of Court and General Meeting
11th Jun 202512:19 pmRNSResult of Court Meeting and General Meeting
11th Jun 202510:55 amRNSForm 8.5 (EPT/RI)
11th Jun 202510:55 amRNSAnnual General Meeting Statement
10th Jun 202510:52 amRNSForm 8.5 (EPT/RI)
9th Jun 202512:05 pmRNSResponse to media speculation
9th Jun 202512:01 pmRNSForm 8.5 (EPT/RI)
6th Jun 202510:21 amRNSForm 8.5 (EPT/RI)
5th Jun 202510:06 amRNSForm 8.5 (EPT/RI)
3rd Jun 202510:08 amRNSForm 8.5 (EPT/RI)
2nd Jun 202511:03 amRNSForm 8.5 (EPT/RI)
30th May 20254:15 pmRNSUpdate on RCF utilisation and current trading
30th May 202510:53 amRNSForm 8.5 (EPT/RI)
30th May 20259:44 amRNSStatement regarding Argentex Group
29th May 202511:23 amRNSForm 8.5 (EPT/RI)
29th May 20257:00 amRNSStatement Regarding Argentex Group PLC
28th May 202511:21 amRNSForm 8.5 (EPT/RI)
27th May 202512:09 pmRNSForm 8.5 (EPT/RI)
23rd May 202510:18 amRNSForm 8.5 (EPT/RI)
21st May 20253:30 pmRNSPUBLICATION AND POSTING OF THE SCHEME DOCUMENT
21st May 202512:03 pmRNSForm 8.5 (EPT/RI)
20th May 202510:56 amRNSForm 8.5 (EPT/RI)
19th May 20259:48 amRNSForm 8.5 (EPT/RI)
16th May 202511:59 amRNSForm 8.5 (EPT/RI) Argentex Group PLC
15th May 202510:11 amRNSForm 8.5 (EPT/RI)
14th May 202511:05 amRNSForm 8.5 (EPT/RI)
13th May 202511:50 amRNSForm 8.5 (EPT/RI)- Argentex Group PLC
12th May 202511:00 amRNSForm 8.5 (EPT/RI)
9th May 202511:15 amRNSForm 8.5 (EPT/RI)
8th May 202510:41 amRNSForm 8.5 (EPT/RI)
7th May 20251:15 pmRNSForm 8 (OPD) (Argentex Group PLC)
7th May 20251:15 pmRNSForm 8.3 - Argentex Group PLC
7th May 202511:30 amRNSRule 2.9 Announcement
7th May 202510:52 amRNSForm 8.5 (EPT/RI)
7th May 20259:55 amRNSForm 8.3 - Argentex Group plc
6th May 20256:32 pmRNSForm 8.3 - Argentex Group plc
6th May 20254:17 pmRNSForm 8.3 - Argentex Group Plc.
6th May 20257:30 amRNSRestoration - Argentex Group Plc
6th May 20257:12 amRNSBoard Changes
6th May 20257:00 amRNSRevolving Credit Facility & Restoration of Trading
2nd May 20254:41 pmRNSForm 8.3 - Argentex Group PLC
30th Apr 202510:45 amRNSExtension to Bridging Loan
25th Apr 20251:38 pmRNSRecommended Cash Acquisition
25th Apr 20259:17 amRNSForm 8.3 - Argentex Group PLC
25th Apr 20258:55 amRNSBoard Change
24th Apr 20254:10 pmRNSUpdate re. Possible Offer & Bridge Funding
24th Apr 20252:28 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: ARGENTEX GROUP PLC
24th Apr 20259:26 amRNSForm 8.3 - Argentex Group Plc
23rd Apr 202512:46 pmRNSForm 8.3 - Argentex Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.